In this book, the authors present current research in the study of non-small cell lung cancer. Topics discussed include the preclinical and clinical advances of epigenetics in lung cancer; therapeutic antibodies and non-coding RNAs (ncRNAs) in non-small cell lung cancer; molecular profiling in lung cancer specimens leads to targeted therapeutic options in patients with non-small cell lung carcinoma; the role of radiation dose escalation in the treatment of stage III locally advanced inoperable non-small cell lung cancer; and mechanisms of resistance to EGFR inhibitors.
Preface; Therapeutic Antibodies in Non-Small Cell Lung Cancer:: An Overview & Future Directions; Non-Coding RNAs (ncRNAs) in Non-small Cell Lung Cancer (NSCLC); Epigenetics in Lung Cancer:: Preclinical & Clinical Advances; Molecular Profiling in Lung Cancer Specimens Leads to Targeted Therapeutic Options in Patients with Non-Small Cell Lung Carcinoma (NSCLC); The Role of Radiation Dose Escalation in the Treatment of Stage III Locally Advanced Inoperable Non-Small Cell Lung Cancer:: Where Are We Now?; Mechanisms of Resistance to EGFR Inhibitors; Index.
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.